Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
    1.
    发明授权
    Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof 有权
    抑制香草素受体亚型1(VR1)的噻吩并吡啶基化合物及其用途

    公开(公告)号:US08501769B2

    公开(公告)日:2013-08-06

    申请号:US12968666

    申请日:2010-12-15

    IPC分类号: A01N43/42 A61K31/44

    CPC分类号: C07D495/04 C07D498/04

    摘要: The present invention discloses fused thienopyridyl compounds of general formula (I) wherein X1-X6, R5-R7, Z1 and L are as defined in the description. The resent invention also discloses a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain, urinary incontinence, bladder overactivity, and inflammatory thermal hyperalgesia in mammals, and pharmaceutical compositions including those compounds.

    摘要翻译: 本发明公开了通式(I)的稠合噻吩并吡啶基化合物,其中X1-X6,R5-R7,Z1和L如说明书中所定义。 本发明还公开了使用这些化合物抑制哺乳动物中的VR1受体的方法,用于控制哺乳动物中的疼痛,尿失禁,膀胱过度活动和炎性热痛觉过敏的方法,以及包括那些化合物的药物组合物。